Skip to content

Type: Peer Reviewed Publications

2020 Scientific Report

JITC – Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms

An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer

Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned From a Novel Pilot Program

2017 Scientific Report: Regulatory Advancements for Patients

Use of FDA-Approved and Laboratory-Developed Tests in Advanced Non-Small Cell Lung Cancer: Results of a Retrospective Market Analysis

Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer

Achieving the goals of effective, safe, and individualized cancer care.

Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe.

Reducing the toxicity of cancer therapy: recognizing needs, taking action.